Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Liver Neoplasms × Electrochemotherapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Vulvar Neoplasms 2 Melanoma 2 Liver Metastases 2 Breast Neoplasms 2 Ulcer 1 Skin Neoplasms 1 Recurrence 1 Rectal Neoplasms 1 Pathologic Processes 1 Pancreatic Neoplasms 1 Neoplastic Processes 1 Neoplasms 1 Neoplasm Metastasis 1 Melanoma, Cutaneous Malignant 1 Liver Neoplasms 1 Head and Neck Neoplasms 1 Gynecological Cancers 1 Colorectal Neoplasms 1

Interventions

Sorafenib 57 Bevacizumab 36 Oxaliplatin 24 Fluorouracil 20 Doxorubicin 19 durvalumab 17 Nivolumab 17 Gemcitabine 17 pembrolizumab 16 Radiosurgery 16 Radiofrequency Ablation 16 Cisplatin 15 lenvatinib 14 Capecitabine 14 Leucovorin 13 atezolizumab 11 tremelimumab 10 Radiotherapy 10 Cyclophosphamide 10 Irinotecan 9 Carboplatin 9 Ipilimumab 8 Drug Therapy 8 Cryosurgery 8 fludarabine 7 Everolimus 7 Chemotherapy, Adjuvant 7 toripalimab 6 Sunitinib 6 Melphalan 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02291133 2021-07-23

ECT-HCC

University Medical Centre Ljubljana

Phase 1/2 Completed

25 enrolled 6 charts

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡